TUNEL-positive cells in the surgical border of an amputation due to infected diabetic foot

Abstract

Abstract. Diabetic infected foot is the outcome of progressive vascular and neurological damage caused by persistent chronic hyperglycemia. Due to acute hypoxia and infection, the tissues develop extensive necrosis and gangrene, which often require amputation. The decision regarding the level of amputation relies mainly on the personal experience of the surgeon who must identify the healthy tissue without necrosis. However, tissue cells under stress may succumb before clear evidence of necrosis is present. In this study, dying cells with DNA damage were identified in the necrotic lesions and surgical borders of amputations. Therefore, the main purpose of this study was to identify apoptosis in the surgical borders of amputations required to treat infected diabetic foot. Apoptosis was identified by terminal deoxynucleotidyl transferase-mediated bio-dUTP nick-end labeling (TUNEL) in the superficial and deep tissues of wounds, and in the surgical borders of 10 consecutive adult patients with diabetes mellitus type 2 (DM2) who underwent amputation due to infected diabetic foot. The severity of the disease was classified by the Acute Physiological and Chronic Health Evaluation II (APACHE II) score on admission, and laboratory data were collected and bacteriological cultures were obtained from the lesions. The ankle/arm blood pressure index was measured, the blood flow in the affected limb was evaluated by high-resolution ultrasonography and color Doppler and pulse oximetry were performed during surgery. A total of 5 males and 5 females, aged 45-84 years (58.8±14.1), were included. The APACHE II score was 2-18 points (8±5.7). A total of 9 patients developed sepsis and 2 succumbed. A total of 5 patients required above-ankle amputation, and 5 required toe disarticulation. The ankle/ arm blood pressure index ranged from 0.23-0.85 (0.51±0.23). Apoptotic cells were found in ulcers and abscesses, and in areas without necrosis. In the surgical borders of the amputations, apoptotic cells were found in skeletal muscle, blood vessels and periphe ral nerves, particularly Schwann cells. Morphometric analysis revealed that the extent of apoptosis was 2-3 logarithms higher in the surgical borders of the infected diabetic foot compared to the venous ulcers, which were used as the reference. In conclusion, apoptosis was identified in regenerating tissues within diabetic foot wounds and in the surgical borders of amputations, where the surgeon considered the tissues to be undamaged. This information suggests that apoptosis may be present before visible signs of necrosis appear in the diabetic foot and may be caused by hypoxia, acidosis or proinflammatory cytokines. The extent of apoptosis in tissues proximal to necrotic areas may anticipate the development of diabetic foot and help the surgeon to make decisions regarding the need and extent of amputation.

Mouse IP-10 Gene Delivered by Folate-modified Chitosan Nanoparticles and Dendritic/tumor Cells Fusion Vaccine Effectively Inhibit the Growth of Hepatocellular Carcinoma in Mice

“…In the present study, the combination of FA-chitosan/mIP-10 and FC vaccine significantly reduced the number of Ki67 + tumor cells but increased the number of apoptotic cells in the tumor tissues which was consistent with the previous reports 31, 32, 33. These data suggest that Th1 and CTL cells induced by combination therapy inhibit the proliferation of tumor cells and trigger apoptosis by direct cell-cell contact or indirectly by soluble mediators.…”

Diabetes-induced glucolipotoxicity impairs wound healing ability of adipose-derived stem cells-through the miR-1248/CITED2/HIF-1α pathway

“…Besides, diabetic hostderived MSCs have been partially impaired in biological function and reduced ability for promoting wound healing [25]. In previous studies, we also confirmed that diabetic host-derived hADSCs have impaired healing capacity compared with normal hADSCs [26]. Thus, extensive preclinical studies aimed at increasing stem cell viability are needed for developing more effective approaches to regeneration therapy using hADSC transplantation.…”

“…The procedures were approved by the Ethics Committee at the Affiliated hospital of Zunyi Medical University, with patient consent obtained before the procedure. hADSCs were isolated as previously described [26]. Briefly, the adipose tissue was minced, washed, and digested with 0.075% collagenase type I (Sigma, St. Louis, MO, USA) for 45 min in a shaker incubator at 37°C.…”

Adipose stem cells from type 2 diabetic mice exhibit therapeutic potential in wound healing

“…Diabetic patients often suffer from both microvascular and macrovascular disease caused by ischemia and hypoxia [ 35 – 37 ]. A long-term hyperglycemic microenvironment in diabetes leads to microvascular cell loss and blood flow abnormalities.…”